Originally posted on Cannabiz.
US firm Vantage Hemp is closing in on Good Manufacturing Practice (GMP) certification after inking a deal with Medcan to import its pharmaceutical-grade CBD into Australia last year.
The Colorado-based firm said the TGA completed a four-day audit of its operations in August focused on compliance with the Pharmaceutical Inspection Co-operation Scheme (PIC/S) and TGO93.
Vantage said there were no critical observations noted during the inspection.
Chief Operating Officer Deepank Utkhede added: “As a result of the audit, Vantage is poised to receive its GMP certificate from the TGA in the coming months, cementing our status as a compliant, transparent, and reliable partner for companies seeking to navigate this complex landscape.”
